Clinical evidence suggests these medications may actually improve liver health by reducing hepatic fat content and inflammation markers, though patients with decompensated cirrhosis require individualized specialist assessment
Fact: Current evidence doesnt show this
Current avenues of research include randomized trials in assisted reproduction contexts, dose-finding investigations, and biomarker efforts to connect antioxidant and matrix changes to the success of embryo implantation
Unlike traditional anti-inflammatories that only reduce pain, TB500 may actually stimulate repair in connective tissues
Additionally, TMAO induces oxidative stress and activates NLRP3 inflammasomes through the MAPK pathway, thereby impairing renal function and inducing renal fibrosis (Andrikopoulos et al., 2023)
As we pointed out above, to date no pathogenic antibodies, ones that primarily drive the disease process, have been convincingly detected in MS